Financial Ratios

STERLING BIOTECH LTD.

NSE : STERLINBIOBSE : 512299ISIN CODE : INE324C01038Industry : ChemicalsHouse : Sandesara
BSE0.770 (0 %)
PREV CLOSE ( ) 0.77
OPEN PRICE ( ) 0.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.77 (38071)
VOLUME 45051
TODAY'S LOW / HIGH ( )0.77 0.85
52 WK LOW / HIGH ( )0.77 0.85
NSE0.700 (0 %)
PREV CLOSE( ) 0.70
OPEN PRICE ( ) 0.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16887
TODAY'S LOW / HIGH( ) 0.65 0.75
52 WK LOW / HIGH ( )0.65 0.75
Select year
ParticularsMar2018Mar2017Mar2016Dec2014Dec2013
Operational & Financial Ratios
   Earnings Per Share (Rs)-36.94-15.15-16.55-16.82-14.96
   CEPS(Rs)-27.91-5.47-3.87-6.66-5.46
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)10.1446.8961.1338.1454.88
   Tax Rate(%)30.0933.1334.4930.9132.45
Margin Ratios
   Core EBITDA Margin(%)3.923.1411.5011.9813.19
   EBIT Margin(%)-277.56-61.72-48.68-28.93-21.64
   Pre Tax Margin(%)-399.78-154.13-122.67-99.33-82.59
   PAT Margin (%)-279.49-103.06-80.37-68.63-55.80
   Cash Profit Margin (%)-211.17-37.21-18.79-27.16-20.38
Performance Ratios
   ROA(%)-13.37-5.11-5.95-6.39-5.55
   ROE(%)-129.56-28.06-33.35-36.51-23.98
   ROCE(%)-12.49-3.00-3.55-3.09-2.86
   Asset Turnover(x)0.050.050.070.090.10
   Sales/Fixed Asset(x)0.110.120.130.130.15
   Working Capital/Sales(x)-0.07-0.20-0.38-0.38-0.20
Efficiency Ratios
   Fixed Capital/Sales(x)9.158.217.417.466.82
   Receivable days48.0339.0372.54141.27173.54
   Inventory Days387.72647.95440.22390.77422.77
   Payable days42.5240.2024.2117.5416.60
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-0.06-0.79-1.02-1.05-1.57
   Price/Book(x)0.160.090.060.180.16
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)21.3619.1312.719.415.70
   EV/Core EBITDA(x)383.95425.9292.0975.1041.39
   EV/EBIT(x)-7.54-28.54-24.41-32.53-26.36
   EV/CE(x)1.070.880.810.900.56
   M Cap / Sales0.130.320.210.280.32
Growth Ratio
   Net Sales Growth(%)-4.37-29.69-21.43-7.12-13.98
   Core EBITDA Growth(%)18.41-77.11-13.50-15.51-36.01
   EBIT Growth(%)-304.239.47-41.38-24.20-47.38
   PAT Growth(%)-143.768.441.58-14.24-14.55
   EPS Growth(%)-143.768.441.62-12.49-14.55
Financial Stability Ratios
   Total Debt/Equity(x)27.165.453.951.812.64
   Current Ratio(x)0.090.350.420.380.29
   Quick Ratio(x)0.070.120.130.150.13
   Interest Cover(x)-2.27-0.67-0.66-0.41-0.35
   Total Debt/Mcap(x)165.8459.3860.9424.2216.89

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.